GSK3iXV

Known as: GSK3 inhibitor XV 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2015
01220072015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In cancer, the deregulation of growth signaling pathways drives changes in the cell's architecture and its environment that allow… (More)
Is this relevant?
2015
2015
Molecular mechanism behind palmitate associated insulin resistance (IR) and podocyte death is not yet fully understood. The… (More)
Is this relevant?
2015
2015
Cytochrome P450 (CYP) expression and activity are not homogeneous in the liver lobules. Indeed, CYPs are mainly expressed and… (More)
Is this relevant?
2013
2013
Although recent progress has been made in treating castration resistant prostate cancer, the interplay of signaling pathways… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2007
2007
Selective glycogen synthase kinase 3 (GSK3) inhibition over cyclin dependent kinases such as cyclin dependent kinase 2 (CDK2) and… (More)
Is this relevant?